POLYTHIAZIDE AND RESERPINE COMBINED IN THE OFFICE TREATMENT OF HYPERTENSION.
D000959:Antihypertensive Agents; D001581:Benzothiadiazines; D035843:Biomedical Research; D001769:Blood; D004232:Diuretics; D005759:Gastroenteritis; D005853:Geriatrics; D006073:Gout; D006973:Hypertension; D009584:Nitrogen; D011139:Polythiazide; D011379:Prognosis; D012110:Reserpine; D014116:Toxicology; D014527:Uric Acid; D014717:Vertigo; D014882:Water-Electrolyte Balance
D000959:Antihypertensive Agents; D001581:Benzothiadiazines; D004232:Diuretics; D014527:Uric Acid; D011139:Polythiazide; D012110:Reserpine; D009584:Nitrogen
ANTIHYPERTENSIVE AGENTS; BENZOTHIADIAZINES; BLOOD; CLINICAL RESEARCH; DIURETICS; GASTROENTERITIS; GERIATRICS; GOUT; NITROGEN; POLYTHIAZIDE; PROGNOSIS; RESERPINE; TOXICOLOGIC REPORT; URIC ACID; VERTIGO; WATER-ELECTROLYTE BALANCE